Oscar Health Quarterly Balance Sheets Chart
Quarterly
|
Annual
Oscar Health Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||
| current assets: | ||||||||||||||||||
| cash and cash equivalents | 2,598,942,000 | 2,236,555,000 | 1,527,186,000 | 1,206,145,000 | 2,268,154,000 | 2,230,799,000 | 1,870,315,000 | 1,399,791,000 | 2,322,069,000 | 2,109,571,000 | 1,558,595,000 | 2,112,930,000 | 2,362,632,000 | 2,068,632,000 | 1,103,995,000 | 1,076,699,000 | 1,671,540,000 | 2,321,287,000 |
| short-term investments | 938,102,000 | 751,489,000 | 624,461,000 | 503,784,000 | 363,639,000 | 616,134,000 | 689,833,000 | 1,044,445,000 | 1,255,705,000 | 1,324,544,000 | 1,397,287,000 | 718,228,000 | 909,006,000 | 810,002,000 | 587,086,000 | 586,954,000 | 614,979,000 | 389,016,000 |
| premiums and accounts receivable | 465,399,000 | 488,766,000 | 315,891,000 | 300,635,000 | 398,366,000 | 342,904,000 | 201,269,000 | 207,098,000 | 193,079,000 | 186,035,000 | 215,471,000 | 174,249,000 | 157,298,000 | |||||
| risk adjustment transfer receivable | 87,617,000 | 87,126,000 | 64,779,000 | 63,512,000 | 72,136,000 | 62,037,000 | 51,925,000 | 54,127,000 | 60,335,000 | 48,122,000 | 49,861,000 | 44,256,000 | 54,518,000 | 50,615,000 | 40,659,000 | 43,099,000 | 39,917,000 | 37,765,000 |
| reinsurance recoverable | 192,698,000 | 187,546,000 | 291,537,000 | 273,317,000 | 241,284,000 | 242,935,000 | 241,194,000 | 277,803,000 | 353,883,000 | 452,235,000 | 892,887,000 | 824,478,000 | 740,204,000 | 585,688,000 | ||||
| other current assets | 30,464,000 | 23,018,000 | 21,320,000 | 20,661,000 | 15,514,000 | 8,983,000 | 6,564,000 | 8,358,000 | 7,561,000 | 10,712,000 | 6,450,000 | 15,811,000 | 19,541,000 | |||||
| total current assets | 4,313,222,000 | 3,774,500,000 | 2,845,174,000 | 2,368,054,000 | 3,359,093,000 | 3,503,792,000 | 3,061,100,000 | 2,991,622,000 | 4,192,632,000 | 4,131,219,000 | 4,121,555,000 | 3,931,174,000 | 4,260,150,000 | 3,674,819,000 | 2,305,926,000 | 2,241,161,000 | 2,816,033,000 | 3,179,360,000 |
| property, equipment, and capitalized software | 77,669,000 | 71,998,000 | 66,793,000 | 66,631,000 | 63,953,000 | 61,406,000 | 61,930,000 | 62,022,000 | 63,053,000 | 64,083,000 | 59,888,000 | 56,492,000 | 50,934,000 | 48,607,000 | 46,611,000 | 43,376,000 | 40,874,000 | 38,993,000 |
| long-term investments | 1,845,884,000 | 1,872,677,000 | 1,815,254,000 | 1,933,892,000 | 1,465,974,000 | 736,624,000 | 365,309,000 | 179,633,000 | 189,638,000 | 165,239,000 | 222,919,000 | 196,454,000 | 314,836,000 | 502,149,000 | 844,476,000 | 838,273,000 | 803,289,000 | 329,597,000 |
| restricted deposits | 31,086,000 | 31,010,000 | 30,878,000 | 30,069,000 | 29,856,000 | 29,814,000 | 29,870,000 | 27,335,000 | 27,292,000 | 27,287,000 | 27,483,000 | 27,459,000 | 27,179,000 | 27,198,000 | 28,085,000 | 27,757,000 | 26,455,000 | 26,449,000 |
| other assets | 116,266,000 | 93,584,000 | 82,397,000 | 84,369,000 | 87,273,000 | 87,217,000 | 83,271,000 | 88,899,000 | 92,330,000 | 95,202,000 | 94,756,000 | 97,130,000 | 98,068,000 | 97,153,000 | 95,957,000 | 18,828,000 | 19,368,000 | 19,472,000 |
| total assets | 6,384,127,000 | 5,843,769,000 | 4,840,496,000 | 4,483,015,000 | 5,006,149,000 | 4,418,853,000 | 3,601,480,000 | 3,349,511,000 | 4,564,945,000 | 4,483,030,000 | 4,526,601,000 | 4,308,709,000 | 4,751,167,000 | 4,350,521,000 | 3,321,650,000 | 3,169,880,000 | 3,706,486,000 | 3,594,356,000 |
| liabilities and stockholders' equity | ||||||||||||||||||
| current liabilities: | ||||||||||||||||||
| benefits payable | 1,551,632,000 | 1,465,578,000 | 1,356,730,000 | 1,356,726,000 | 1,252,228,000 | 1,248,347,000 | 965,986,000 | 910,449,000 | 855,711,000 | 954,076,000 | 937,727,000 | 995,760,000 | 880,527,000 | 761,329,000 | 513,582,000 | 497,324,000 | 407,322,000 | 358,066,000 |
| risk adjustment transfer payable | 2,647,187,000 | 1,954,451,000 | 1,558,341,000 | 1,083,880,000 | 1,779,039,000 | 1,336,022,000 | 1,056,941,000 | 751,196,000 | 1,982,999,000 | 1,810,155,000 | 1,517,493,000 | 1,078,694,000 | 1,498,332,000 | 1,166,059,000 | 794,398,000 | 613,230,000 | 1,043,863,000 | 922,069,000 |
| unearned premiums | 69,489,000 | 70,897,000 | 74,389,000 | 66,129,000 | 59,970,000 | 65,541,000 | 65,918,000 | 71,601,000 | 73,072,000 | 73,349,000 | 78,998,000 | 75,134,000 | 72,691,000 | 74,700,000 | 75,044,000 | 56,175,000 | 63,882,000 | 71,946,000 |
| accounts payable and other liabilities | 583,871,000 | 634,007,000 | 432,428,000 | 395,481,000 | 347,523,000 | 303,245,000 | 273,367,000 | 260,137,000 | 261,519,000 | 299,461,000 | 252,358,000 | 226,274,000 | 220,516,000 | |||||
| reinsurance payable | 13,380,000 | 23,643,000 | 41,346,000 | 51,117,000 | 60,094,000 | 61,938,000 | 61,024,000 | 67,314,000 | 67,635,000 | 40,458,000 | 427,649,000 | 435,632,000 | 430,919,000 | 392,235,000 | 205,231,000 | 221,311,000 | 248,142,000 | 260,055,000 |
| total current liabilities | 4,865,559,000 | 4,148,576,000 | 3,463,234,000 | 2,954,777,000 | 3,501,741,000 | 3,019,425,000 | 2,429,012,000 | 2,060,876,000 | 3,244,317,000 | 3,181,698,000 | 3,263,922,000 | 2,852,544,000 | 3,130,248,000 | 2,640,880,000 | 1,852,289,000 | 1,616,668,000 | 1,972,655,000 | 1,808,119,000 |
| long-term debt | 299,944,000 | 299,749,000 | 299,555,000 | 299,361,000 | 299,166,000 | 298,972,000 | 298,777,000 | 298,583,000 | 298,388,000 | 298,194,000 | 297,999,000 | 297,805,000 | 297,610,000 | 297,416,000 | ||||
| other liabilities | 57,274,000 | 59,329,000 | 61,282,000 | 63,537,000 | 64,674,000 | 66,169,000 | 67,574,000 | 68,618,000 | 70,275,000 | 71,376,000 | 72,280,000 | 73,791,000 | 74,906,000 | 77,058,000 | 76,839,000 | |||
| total liabilities | 5,222,777,000 | 4,507,654,000 | 3,824,071,000 | 3,317,675,000 | 3,865,581,000 | 3,384,566,000 | 2,795,363,000 | 2,428,077,000 | 3,612,980,000 | 3,551,268,000 | 3,634,201,000 | 3,224,140,000 | 3,502,764,000 | 3,015,354,000 | 1,929,128,000 | 1,616,668,000 | 1,972,655,000 | 1,808,119,000 |
| commitments and contingencies | ||||||||||||||||||
| stockholders' equity | ||||||||||||||||||
| class a common stock | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| class b common stock | ||||||||||||||||||
| treasury stock | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 | -2,923,000 |
| additional paid-in capital | 3,951,980,000 | 3,902,373,000 | 3,869,617,000 | 3,837,369,000 | 3,786,885,000 | 3,736,885,000 | 3,682,294,000 | 3,653,535,000 | 3,620,766,000 | 3,582,761,000 | 3,509,007,000 | 3,479,392,000 | 3,450,409,000 | 3,422,033,000 | 3,393,533,000 | 3,356,406,000 | 3,324,337,000 | 3,303,031,000 |
| accumulated deficit | -2,804,373,000 | -2,576,012,000 | -2,851,283,000 | -2,697,736,000 | -2,643,140,000 | -2,699,347,000 | -2,876,715,000 | -2,726,685,000 | -2,661,287,000 | -2,645,759,000 | -2,605,987,000 | -2,379,941,000 | -2,187,028,000 | -2,074,864,000 | -1,999,712,000 | -1,800,290,000 | -1,587,545,000 | -1,514,477,000 |
| accumulated other comprehensive income | 13,720,000 | 9,601,000 | -1,827,000 | 26,051,000 | -2,625,000 | -2,594,000 | 1,309,000 | -4,453,000 | -6,856,000 | -4,479,000 | -14,491,000 | -15,221,000 | -12,206,000 | -3,671,000 | 17,000 | -40,000 | 604,000 | |
| total oscar health, inc. stockholders' equity | 1,158,406,000 | 1,333,041,000 | 1,162,763,000 | 1,138,199,000 | 1,032,023,000 | 919,476,000 | 949,702,000 | 929,602,000 | 1,082,039,000 | 1,245,239,000 | 1,332,042,000 | |||||||
| noncontrolling interests | 2,944,000 | 3,074,000 | 2,839,000 | 2,577,000 | 2,369,000 | 2,264,000 | 2,150,000 | 1,958,000 | 2,263,000 | 2,160,000 | 2,016,000 | 2,530,000 | 3,164,000 | 3,125,000 | 5,293,000 | |||
| total stockholders' equity | 1,161,350,000 | 1,336,115,000 | 1,165,340,000 | 1,140,568,000 | 1,034,287,000 | 921,434,000 | 951,965,000 | 931,762,000 | 1,084,569,000 | 1,248,403,000 | ||||||||
| total liabilities and stockholders' equity | 6,384,127,000 | 5,843,769,000 | 4,840,496,000 | 4,483,015,000 | 5,006,149,000 | 4,418,853,000 | 3,601,480,000 | 3,349,511,000 | 4,564,945,000 | 4,483,030,000 | 4,526,601,000 | 4,308,709,000 | 4,751,167,000 | 4,350,521,000 | ||||
| premium deficiency reserve | 1,444,000 | 2,887,000 | 4,332,000 | 5,776,000 | 179,000 | 3,381,000 | 4,199,000 | 4,214,000 | 14,966,000 | 21,505,000 | 26,041,000 | 29,246,000 | 69,432,000 | 74,107,000 | 75,029,000 | |||
| total oscar health, inc. stockholders’ equity | 1,013,586,000 | 803,967,000 | 890,384,000 | 1,387,229,000 | ||||||||||||||
| total stockholders’ equity | 1,016,425,000 | 806,117,000 | 892,400,000 | 1,335,167,000 | 1,392,522,000 | 1,553,212,000 | 1,733,831,000 | 1,786,237,000 | ||||||||||
| assets: | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none outstanding as of september 30, 2023 and december 31, 2022 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of june 30, 2023 and december 31, 2022 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of march 31, 2023 and december 31, 2022 | ||||||||||||||||||
| premium and other receivables | 216,475,000 | 138,414,000 | 117,534,000 | 85,629,000 | 75,851,000 | |||||||||||||
| accounts payable and accrued liabilities | 297,841,000 | 234,788,000 | 159,196,000 | 135,339,000 | 120,954,000 | |||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of december 31, 2022 and 2021 | ||||||||||||||||||
| accumulated other comprehensive loss | -9,715,000 | |||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of september 30, 2022 and december 31, 2021 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of june 30, 2022 and december 31, 2021 | ||||||||||||||||||
| accrued investment income | 2,584,000 | 3,782,000 | 3,086,000 | 3,794,000 | 1,445,000 | |||||||||||||
| net deferred tax asset | 595,000 | 595,000 | 485,000 | 467,000 | 485,000 | |||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of march 31, 2022 and december 31, 2021 | ||||||||||||||||||
| balances due from reinsurance programs | 431,990,000 | 413,789,000 | 400,174,000 | 353,996,000 | ||||||||||||||
| liabilities, convertible preferred stock and stockholders' equity | ||||||||||||||||||
| warrant liabilities | ||||||||||||||||||
| convertible preferred stock, 0.00001 par value; 407,156,831 shares authorized; 400,904,302 shares issued and outstanding as of december 31, 2020 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of december 31, 2021 | ||||||||||||||||||
| series a common stock, 0.00001 par value, 680,000,000 shares authorized; 8,291,917 issued and outstanding as of december 31, 2020; series b common stock, 0.00001 par value, 69,487,963 shares authorized; 23,162,654 shares issued and outstanding as of december 31, 2020; series c common stock, 0.00001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2020 | ||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders' equity | 3,321,650,000 | 3,169,880,000 | 3,706,486,000 | 3,594,356,000 | ||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of september 30, 2021 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of june 30, 2021 | ||||||||||||||||||
| preferred stock, 0.00001 par value; 82,500,000 shares authorized, none issued or outstanding as of march 31, 2021 | ||||||||||||||||||
| series a common stock, 0.00001 par value, 680,000,000 shares authorized; 8,291,917 issued and outstanding; series b common stock, 0.00001 par value, 69,487,963 shares authorized; 23,162,654 shares issued and outstanding as of december 31, 2020; series c common stock, 0.00001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of december 31, 2020 |
We provide you with 20 years of balance sheets for Oscar Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Oscar Health. Explore the full financial landscape of Oscar Health stock with our expertly curated balance sheets.
The information provided in this report about Oscar Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.